UiPath’s Q4 results show margin improvements, but analyst cautions on AI transition and growth pressure, lowering price target to $12.
UiPath Stock Down: Faces Caution Despite Margin Gains, Analyst Doubtful About Company’s AI Transition Capability
Where Today's News Shapes Tomorrow
